BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 6652024)

  • 21. [Sensitivity of the occult blood test in the diagnosis of colorectal polyps].
    Giacchero A; Munizzi F; Pugliese V; Aste H
    Minerva Dietol Gastroenterol; 1982; 28(4):321-3. PubMed ID: 7167244
    [No Abstract]   [Full Text] [Related]  

  • 22. [Screening tests for colon cancer - a new comparison Haemoccult - hemoFEC and review of 9 years clinical experience with Haemoccult (author's transl)].
    Gnauck R
    Z Gastroenterol; 1982 Feb; 20(2):84-92. PubMed ID: 6977955
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Screening for colorectal cancer.
    Mitchell P; Silman A
    Nurs Times; 1983 Mar 2-8; 79(9):58-61. PubMed ID: 6550857
    [No Abstract]   [Full Text] [Related]  

  • 24. Faecal occult blood testing in symptomatic patients: comparison of three tests.
    Tate JJ; Northway J; Royle GT; Taylor I
    Br J Surg; 1990 May; 77(5):523-6. PubMed ID: 2354334
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Results of a mass screening program for colorectal cancer.
    Miller MP; Stanley TV
    Arch Surg; 1988 Jan; 123(1):63-5. PubMed ID: 3337658
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Screening for colorectal cancer.
    Sterchi JM
    South Med J; 1979 Sep; 72(9):1144-6. PubMed ID: 472841
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Screening for colorectal cancer using the Hemoccult II stool guaiac slide test.
    Cummings KM; Michalek A; Mettlin C; Mittelman A
    Cancer; 1984 May; 53(10):2201-5. PubMed ID: 6704908
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunochemical testing of individuals positive for guaiac faecal occult blood test in a screening programme for colorectal cancer: an observational study.
    Fraser CG; Matthew CM; Mowat NA; Wilson JA; Carey FA; Steele RJ
    Lancet Oncol; 2006 Feb; 7(2):127-31. PubMed ID: 16455476
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Methodological framework of the evaluation of systematic screening and treatment of preexistent lesions of the colon and the rectum].
    Flamant R; Doyon F; Mollie A
    Soz Praventivmed; 1986; 31(2):91-3. PubMed ID: 3087085
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sensitivity and specificity of the fecal occult blood test for colorectal neoplasia.
    Winawer SJ; Fleisher M
    Gastroenterology; 1982 May; 82(5 Pt 1):986-91. PubMed ID: 7060917
    [No Abstract]   [Full Text] [Related]  

  • 31. Colorectal polyps: an endoscopic experience.
    Isbister WH
    Aust N Z J Surg; 1986 Sep; 56(9):717-22. PubMed ID: 3467704
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A comparison of an immunological faecal occult blood test Fecatwin sensitive/FECA EIA with Haemoccult in population screening for colorectal cancer.
    Armitage N; Hardcastle JD; Amar SS; Balfour TW; Haynes J; James PD
    Br J Cancer; 1985 Jun; 51(6):799-804. PubMed ID: 4005139
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fecal occult blood screening for colorectal cancer in a Veterans Administration Hospital.
    Sontag SJ; Durczak C; Aranha GV; Chejfec G; Frederick W; Greenlee HB
    Am J Surg; 1983 Jan; 145(1):89-94. PubMed ID: 6849498
    [No Abstract]   [Full Text] [Related]  

  • 34. Screening for colorectal tumors - results of two years experience.
    Ribet A; Escourrou J; Frexinos J; Delpu J
    Cancer Detect Prev; 1980; 3(2):449-61. PubMed ID: 7337921
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A cooperative study on the detection of colorectal cancer and polyps in France.
    Martin F; Poynard T; Ribet A; Escourrou J; Delpu J; Klepping C; Bernier JJ; Soullard J; Marti R; Nisard A; Bader JP; Sarles H; Sahel J; Bonfils S; Vilotte J; Grenier J; Loygue J; Flamant R
    Cancer Detect Prev; 1981; 4(1-4):407-15. PubMed ID: 7349802
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Detection of colorectal cancer.
    Shulman L; Berwick DM; Caufield EA; Knapp ML
    Am Fam Physician; 1986 Jan; 33(1):177-81. PubMed ID: 3942045
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cost benefits of hemoccult screening for colorectal carcinoma.
    Allison JE; Feldman R
    Dig Dis Sci; 1985 Sep; 30(9):860-5. PubMed ID: 3928287
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Patient compliance with screening for fecal occult blood in family practice.
    Hoogewerf PE; Hislop TG; Morrison BJ; Burns SD; Sizto R
    CMAJ; 1987 Aug; 137(3):195-8. PubMed ID: 3607662
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Improved screening for colorectal cancer by immunological detection of occult blood.
    Frommer DJ; Kapparis A; Brown MK
    Br Med J (Clin Res Ed); 1988 Apr; 296(6629):1092-4. PubMed ID: 3132220
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Occult blood in stool. A field trial in cancer screening (author's transl)].
    Durst J; Neumann G; Schmidt K
    Dtsch Med Wochenschr; 1976 Mar; 101(12):440-3. PubMed ID: 1253712
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.